Processa Pharmaceuticals, Inc. Stock
Stocks
PCSA
US74275C4033
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Nasdaq
00:30:00 16/09/2026 +04
|
5-day change | 1st Jan Change | ||
| 1.957 USD | +4.08% |
|
-5.01% | -32.06% |
| Market Cap | 5.47M 4.74M 4.48M 4.06M 7.61M 524M 7.67M 53.42M 20.56M 266M 20.53M 20.07M 848M | P/E 2024 |
-0.23x | P/E 2025 | -0.28x |
|---|---|---|---|---|---|
| Enterprise Value | -71.14K -61.66K -58.26K -52.8K -99.04K -6.82M -99.8K -695K -268K -3.46M -267K -261K -11.04M | EV / Sales 2024 |
-
| EV / Sales 2025 | - |
| Free-Float |
85.18% | Yield 2024 * |
-
| Yield 2025 | - |
NasdaqUSD
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| PCSA | Delayed | |
CBOE
| PCSA | Real-time |
Last Transcript: Processa Pharmaceuticals, Inc.
| 1 day | +4.08% | ||
| 1 week | -5.01% | ||
| Current month | -4.55% | ||
| 1 month | -19.48% | ||
| 3 months | -9.83% | ||
| 6 months | -33.67% | ||
| Current year | -32.06% |
| 1 week | 1.82 |  | 2.12 |
| 1 month | 1.82 | | 2.43 |
| Current year | 1.67 | | 3.8 |
| 1 year | 1.67 | | 14.24 |
| 3 years | 1.67 | | 450 |
| 5 years | 1.67 | | 4,495.35 |
| 10 years | 1.67 | | 125,195.11 |
| Manager | Title | Age | Since |
|---|---|---|---|
George Ng
CEO | Chief Executive Officer | 52 | 08/08/2023 |
Patrick Lin
IRC | Investor Relations Contact | 60 | 29/03/2011 |
Wendy Guy
ADM | Chief Administrative Officer | 61 | 04/10/2017 |
| Director | Title | Age | Since |
|---|---|---|---|
David Young
CHM | Chairman | 73 | 29/03/2011 |
Justin Yorke
CHM | Chairman | 60 | 16/08/2022 |
Geraldine Pannu
BRD | Director/Board Member | 56 | 13/02/2020 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 08/08/26 | Exercice | Chief Executive Officer | 3,200 | 0.1156% | ||
| 26/07/26 | Other | Chief Financial Officer | 11,883 | 0.4293% | ||
| 26/07/26 | Other | Chief Executive Officer | 9,384 | 0.3390% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +4.08% | -5.01% | -58.72% | -98.73% | 5.25M | |
| -1.38% | +2.23% | +48.54% | +100.96% | 70.24B | |
| -1.04% | -1.22% | +33.27% | +74.98% | 62.63B | |
| -4.29% | -5.04% | -17.82% | +349.64% | 27.36B | |
| +0.16% | +1.53% | +34.92% | +17.47% | 25.71B | |
| -2.20% | -6.81% | -0.05% | -15.04% | 24.83B | |
| +1.61% | +0.42% | +19.44% | -20.66% | 19.52B | |
| +1.26% | -9.06% | +165.21% | +308.08% | 15.51B | |
| -3.91% | -5.71% | -8.71% | +521.92% | 14.66B | |
| -5.54% | -1.16% | -8.13% | +810.99% | 14.69B | |
| Average | -1.12% | -2.07% | +20.80% | +204.96% | 27.52B | |
| Weighted average by Cap. | -1.52% | -0.64% | +31.24% | +164.90% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | - | - |
| Net income | -11.85M -10.27M -9.7M -8.8M -16.5M -1.14B -16.62M -116M -44.56M -576M -44.51M -43.52M -1.84B | -13.56M -11.76M -11.11M -10.07M -18.88M -1.3B -19.03M -133M -51.01M -659M -50.95M -49.81M -2.1B |
| Net Debt | -1.12M -969K -915K -830K -1.56M -107M -1.57M -10.93M -4.2M -54.34M -4.2M -4.11M -173M | -5.54M -4.8M -4.53M -4.11M -7.71M -531M -7.77M -54.12M -20.82M -269M -20.8M -20.34M -859M |
Employees
12
| Date | Price | Change | Volume |
|---|---|---|---|
| 15/09/26 | $1.957 | +4.08% | 15,565 |
| 14/09/26 | $1.880 | -9.62% | 26,800 |
| 11/09/26 | $2.080 | +12.43% | 39,353 |
| 10/09/26 | $1.850 | -7.04% | 102,278 |
| 09/09/26 | $1.990 | -7.87% | 25,465 |
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- PCSA Stock
Select your edition
All financial news and data tailored to specific country editions
